BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 29051118)

  • 1. Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance.
    Meng T; Lu B; Shao S; Yuan M; Liu X; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Dec; 534(1-2):368-377. PubMed ID: 29051118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
    Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
    Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
    Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
    Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment.
    Liu X; Zhou XQ; Shang XW; Wang L; Li Y; Yuan H; Hu FQ
    J Zhejiang Univ Sci B; 2020 Mar; 21(3):218-233. PubMed ID: 32133799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
    Zhou Y; Wang S; Ying X; Wang Y; Geng P; Deng A; Yu Z
    Int J Nanomedicine; 2017; 12():6153-6168. PubMed ID: 28883726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells.
    Gao Y; Jia L; Wang Q; Hu H; Zhao X; Chen D; Qiao M
    ACS Appl Mater Interfaces; 2019 May; 11(18):16296-16310. PubMed ID: 30997984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulation.
    Misra R; Das M; Sahoo BS; Sahoo SK
    Int J Pharm; 2014 Nov; 475(1-2):372-84. PubMed ID: 25178825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ; Liu LN; Du YZ; Yuan H
    Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.
    Wang YC; Wang F; Sun TM; Wang J
    Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.
    Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z
    Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier.
    Li JM; Zhang W; Su H; Wang YY; Tan CP; Ji LN; Mao ZW
    Int J Nanomedicine; 2015; 10():3147-62. PubMed ID: 25960653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
    Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
    Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
    Bidwell GL; Davis AN; Fokt I; Priebe W; Raucher D
    Invest New Drugs; 2007 Aug; 25(4):313-26. PubMed ID: 17483874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles.
    Yang S; Zhang B; Zhao X; Zhang M; Zhang M; Cui L; Zhang L
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.